813 related articles for article (PubMed ID: 28379619)
1. Blood pressure lowering efficacy of renin inhibitors for primary hypertension.
Musini VM; Lawrence KA; Fortin PM; Bassett K; Wright JM
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007066. PubMed ID: 28379619
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure lowering efficacy of renin inhibitors for primary hypertension.
Musini VM; Fortin PM; Bassett K; Wright JM
Cochrane Database Syst Rev; 2008 Oct; (4):CD007066. PubMed ID: 18843743
[TBL] [Abstract][Full Text] [Related]
3. Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension.
Wang GM; Li LJ; Tang WL; Wright JM
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012569. PubMed ID: 33089502
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.
Musini VM; Nazer M; Bassett K; Wright JM
Cochrane Database Syst Rev; 2014 May; 2014(5):CD003824. PubMed ID: 24869750
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure lowering efficacy of renin inhibitors for primary hypertension: a Cochrane systematic review.
Musini VM; Fortin PM; Bassett K; Wright JM
J Hum Hypertens; 2009 Aug; 23(8):495-502. PubMed ID: 19158826
[TBL] [Abstract][Full Text] [Related]
6. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Chen YJ; Li LJ; Tang WL; Song JY; Qiu R; Li Q; Xue H; Wright JM
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008170. PubMed ID: 30480768
[TBL] [Abstract][Full Text] [Related]
7. First-line drugs for hypertension.
Wright JM; Musini VM; Gill R
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD001841. PubMed ID: 29667175
[TBL] [Abstract][Full Text] [Related]
8. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension.
Wong GW; Boyda HN; Wright JM
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD007450. PubMed ID: 25427719
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
Li EC; Heran BS; Wright JM
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy for hypertension in adults aged 18 to 59 years.
Musini VM; Gueyffier F; Puil L; Salzwedel DM; Wright JM
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008276. PubMed ID: 28813123
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension.
Wong GW; Boyda HN; Wright JM
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007451. PubMed ID: 26961574
[TBL] [Abstract][Full Text] [Related]
14. First-line diuretics versus other classes of antihypertensive drugs for hypertension.
Reinhart M; Puil L; Salzwedel DM; Wright JM
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD008161. PubMed ID: 37439548
[TBL] [Abstract][Full Text] [Related]
15. Aliskiren and amlodipine in the management of essential hypertension: meta-analysis of randomized controlled trials.
Liu Y; Chen K; Kou X; Han Y; Zhou L; Zeng C
PLoS One; 2013; 8(7):e70111. PubMed ID: 23922924
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of aliskiren and angiotension receptor blockers in the management of essential hypertension.
Zhenfeng Zheng ; Huilan Shi ; Junya Jia ; Dong Li ; Shan Lin
J Renin Angiotensin Aldosterone Syst; 2011 Jun; 12(2):102-12. PubMed ID: 21059822
[TBL] [Abstract][Full Text] [Related]
17. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
[TBL] [Abstract][Full Text] [Related]
18. Aliskiren: an oral renin inhibitor for the treatment of hypertension.
Lam S; Choy M
Cardiol Rev; 2007; 15(6):316-23. PubMed ID: 18090068
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
Saiz LC; Gorricho J; Garjón J; Celaya MC; Erviti J; Leache L
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010315. PubMed ID: 32905623
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
